Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Cardiovascular Drug Reviews|August 31, 2006
Prostanoids in the therapy of glaucomaNaruhiro Ishida, Noriko Odani-Kawabata, Atsushi Shimazaki, et al.Journal of Glaucoma|January 3, 2025
Bioequivalence of Preservative-Free and Preserved Omidenepag Isopropyl 0.002% Ophthalmic Solutions in Patients With Primary Open Angle Glaucoma or Ocular Hypertension: Phase 3 DAISY StudyMakoto Aihara, Fenghe Lu, Toshihiro Ikeda, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|October 28, 2009
Ocular hypotensive effects of anti-glaucoma agents in miceTakahiro Akaishi, Noriko Odani-Kawabata, Naruhiro Ishida, et al.Experimental Eye Research|February 21, 2023
FP and EP2 prostanoid receptor agonist drugs and aqueous humor outflow devices for treating ocular hypertension and glaucomaNajam A Sharif, Noriko Odani-Kawabata, Fenghe Lu, et al.Translational Vision Science & Technology|November 8, 2024
Ocular Tissue Distribution of Omidenepag Isopropyl in Rabbits and Cynomolgus MonkeysKenzo Yamamura, Hidetoshi Mano, Masahiro Fuwa, et al.Japanese Journal of Ophthalmology|September 8, 2021
Twelve-month efficacy and safety of omidenepag isopropyl, a selective EP2 agonist, in open-angle glaucoma and ocular hypertension: the RENGE studyMakoto Aihara, Fenghe Lu, Hisashi Kawata, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 26, 2010
Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbitsTakahiro Akaishi, Hiroaki Kurashima, Noriko Odani-Kawabata, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 15, 2022
Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL StudyDavid L Wirta, Yasuaki Kuwayama, Fenghe Lu, et al.American Journal of Ophthalmology|June 14, 2020
Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME StudyMakoto Aihara, Fenghe Lu, Hisashi Kawata, et al.Journal of Medicinal Chemistry|July 12, 2018
Identification of a Selective, Non-Prostanoid EP2 Receptor Agonist for the Treatment of Glaucoma: Omidenepag and its Prodrug Omidenepag IsopropylRyo Iwamura, Masayuki Tanaka, Eiji Okanari, et al.Pageof 3